
Santen Pharmaceutical said late stage trials for its drug to treat an allergic eye condition in children met its primary …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

